Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.61 0.00 (-0.42%)
As of: Sep 9, 2026 · 3:59 PM EDT

Adagio Medical Holdings (ADGM) Short term Debt (2023)

Adagio Medical Holdings' (ADGM) quarterly Short term Debt came in at $1.7 million in Q4 2023.

Analysis

Adagio Medical Holdings (ADGM) Short term Debt (2023) Analysis & Trends

Adagio Medical Holdings has disclosed Short term Debt across 1 years of filings, most recently posting $1.7 million for Q4 2023.

  • In Q4 2023, Short term Debt changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2023 stood at $1.7 million (changed N/A YoY), while the FY2023 annual figure was $1.7 million, changed N/A from the prior year.
  • Short term Debt came in at $1.7 million for Q4 2023 at Adagio Medical Holdings.
  • In the past five years, Short term Debt ranged from a high of $1.7 million in Q4 2023 to a low of $1.7 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Adagio Medical Holdings 12.44 Mn 12.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.70 Mn